A phase II study of XL184 in patients (pts) with progressive glioblastoma multiforme (GBM) in first or second relapse

被引：0
|
作者：
De Groot, J. F. [1 ,2 ,3 ,4 ,5 ]
Prados, M. [1 ,2 ,3 ,4 ,5 ]
Urquhart, T. [1 ,2 ,3 ,4 ,5 ]
Robertson, S. [1 ,2 ,3 ,4 ,5 ]
Yaron, Y. [1 ,2 ,3 ,4 ,5 ]
Sorensen, A. G. [1 ,2 ,3 ,4 ,5 ]
Norton, A. [1 ,2 ,3 ,4 ,5 ]
Batchelor, T. [1 ,2 ,3 ,4 ,5 ]
Drappatz, J. [1 ,2 ,3 ,4 ,5 ]
Wen, P. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Exelixis Inc, San Francisco, CA USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2047
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Activity of cabozantinib (XL184) in hepatocellular carcinoma patients (pts): Results from a phase II randomized discontinuation trial (RDT)
    Cohn, Allen Lee
    Kelley, Robin Katie
    Yang, Tsai-Shen
    Su, Wu-Chou
    Verslype, Chris
    Ramies, David A.
    Lee, Yihua
    Shen, Xiaodong
    Van Cutsem, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [12] Use of neurovascular imaging in GBM patients (pts) to quantify early physiologic changes after treatment with XL184, an inhibitor of multiple receptor tyrosine kinases: Results from a phase II study
    Sorensen, A. G.
    Jenning, D.
    Wang, M.
    Andronesi, O.
    Chen, P.
    Prados, M.
    Wen, P.
    Jackson, E.
    Cha, S.
    deGroot, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [13] Phase 2 randomized discontinuation trial (RDT) of XL184 in patients (pts) with advanced solid tumors
    Schoeffski, P.
    Sgroi, M.
    Burris, H. A.
    Lutzky, J.
    Rearden, T.
    Sikic, B.
    Stephenson, J., Jr.
    Elhardt, D.
    Lee, Y.
    Kurzrock, R.
    EJC SUPPLEMENTS, 2010, 8 (07): : 117 - 117
  • [14] A phase I study of cabozantinib (XL184) in patients with renal cell cancer
    Choueiri, T. K.
    Pal, S. K.
    McDermott, D. F.
    Morrissey, S.
    Ferguson, K. C.
    Holland, J.
    Kaelin, W. G.
    Dutcher, J. P.
    ANNALS OF ONCOLOGY, 2014, 25 (08) : 1603 - 1608
  • [15] A Phase I Study of Cabozantinib (XL184) in Patients with Differentiated Thyroid Cancer
    Cabanillas, Maria E.
    Brose, Marcia S.
    Holland, Jaymes
    Ferguson, Kimberly C.
    Sherman, Steven I.
    THYROID, 2014, 24 (10) : 1508 - 1514
  • [16] Phase I/II study of dianhydrogalactitol in patients with recurrent malignant glioblastoma multiforme (GBM).
    Shih, Kent C.
    Patel, Manish R.
    Butowski, Nicholas A.
    Bacha, Jeffrey A.
    Brown, Dennis
    Garner, William J.
    Stelno, Anne
    Schwartz, Richard Stephen
    Kanekal, Sarath
    Lopez, Lorena
    Burris, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [17] A phase I study of temozolomide (TMZ) and RAD001 in patients (pts) with glioblastoma multiforme (GBM)
    Mason, W. P.
    MacNeil, M.
    Easaw, J.
    McIntosh, L.
    Lwin, Z.
    Chen, E.
    Eisenhauer, E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [18] PHASE I/II STUDY OF DIANHYDROGALACTITOL IN PATIENTS WITH RECURRENT MALIGNANT GLIOBLASTOMA MULTIFORME (GBM)
    Shih, Kent
    Patel, Manish
    Butowski, Nicholas
    Bacha, Jeffrey
    Brown, Dennis
    Garner, William
    Steino, Anne
    Schwartz, Richard
    Kanekal, Sarath
    Lopez, Lorena
    Burris, Howard A., III
    NEURO-ONCOLOGY, 2014, 16
  • [19] Activity of cabozantinib (XL184) in advanced ovarian cancer patients (pts): Results from a phase II randomized discontinuation trial (RDT).
    Buckanovich, R. J.
    Berger, R.
    Sella, A.
    Sikic, B. I.
    Shen, X.
    Ramies, D. A.
    Smith, D. C.
    Vergote, I. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [20] A phase Ib/II study of XL184 (BMS 907351) with and without erlotinib (E) in patients (pts) with non-small cell lung cancer (NSCLC).
    Wakelee, H. A.
    Gettinger, S. N.
    Engelman, J. A.
    Janne, P. A.
    West, H. J.
    Subramaniam, D. S.
    Leach, J. W.
    Wax, M. B.
    Yaron, Y.
    Lara, P., Jr.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345